Literature DB >> 3304459

The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture.

J Miyauchi, C A Kelleher, Y C Yang, G G Wong, S C Clark, M D Minden, S Minkin, E A McCulloch.   

Abstract

The blast stem cells of acute myeloblastic leukemia (AML) respond in cell culture to growth factors by both self-renewal and terminal divisions. Both of these functions have been shown to be stimulated by the recombinant growth factors granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF). In this paper, recombinant gibbon interleukin-3 (IL-3), homologous to human IL-3, was tested on blast cells and compared with the effects of GM-CSF, G-CSF, and medium conditioned by the bladder cell line 5637 (5637-CM). We found that IL-3 was an effective stimulator of blast renewal and terminal divisions. However, great patient-to-patient variation was found. A graphic method of presenting complex comparisons between growth factors is also included.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3304459

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Clonal growth and self-renewal of human myeloid leukemia cell lines (BRM and DD) in serum-free semi-solid culture.

Authors:  C Kiss
Journal:  Blut       Date:  1990-11

2.  Acute myeloblastic leukemia and recombinant granulocyte colony stimulating factor.

Authors:  R L Soutar
Journal:  BMJ       Date:  1991-07-13

Review 3.  The role of colony-stimulating factors in acute leukemia.

Authors:  F Herrmann; E Vellenga
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers.

Authors:  H J Sutherland; P M Lansdorp; D H Henkelman; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control.

Authors:  W Oster; N A Cicco; H Klein; T Hirano; T Kishimoto; A Lindemann; R H Mertelsmann; F Herrmann
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Differential regulation of umbilical cord blood and leukemic B cells by interferon-alpha (IFN-alpha): observations in cultured cells.

Authors:  István Szegedi; Csongor Kiss; Eva Karászi; György Vámosi; János Szöllôsi; Péter Kovács; Ilona Benkô
Journal:  Pathol Oncol Res       Date:  2006-09-23       Impact factor: 3.201

7.  Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

Authors:  Stefan Gross; Rob A Cairns; Mark D Minden; Edward M Driggers; Mark A Bittinger; Hyun Gyung Jang; Masato Sasaki; Shengfang Jin; David P Schenkein; Shinsan M Su; Lenny Dang; Valeria R Fantin; Tak W Mak
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 17.579

Review 8.  Why clinicians should be interested in interleukin-3.

Authors:  P Valent; K Geissler; C Sillaber; K Lechner; P Bettelheim
Journal:  Blut       Date:  1990-12

9.  Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Authors:  A Pinto; D Aldinucci; V Gattei; V Zagonel; G Tortora; A Budillon; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Granulocyte colony stimulating factor increases drug resistance of leukaemic blast cells to daunorubicin.

Authors:  László Márkász; György Hajas; Andrea Kiss; Beáta Lontay; Eva Rajnavölgyi; Ferenc Erdodi; Eva Oláh
Journal:  Pathol Oncol Res       Date:  2008-05-21       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.